封面
市場調查報告書
商品編碼
1198465

脊柱植入物和手術器械市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Spinal Implants and Surgical Devices Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內(2022 年至 2027 年),脊柱植入物和手術器械市場預計將以 5.6% 的複合年增長率增長。

COVID-19 大流行不僅對感染 COVID-19 的患者產生了重大影響,對其他患者也產生了重大影響,導致脊柱手術被取消以管理和節約資源,導致許多醫院面臨短缺協助這些手術的專家,影響了該國的醫療保健系統。 例如,在 2020 年 5 月發表的題為“由於 COVID-19 大流行導致的選擇性手術取消:為手術恢復計劃提供信息的全球預測模型”的英國外科雜誌上,印度報告稱大約有 48,728 次手術被取消,並且它預計 12 週內將進行約 585,000 台手術。 因此,考慮到上述因素,它可能在 COVID-19 流行期間對研究中的市場產生重大影響。 全球 COVID-19 病例數量的增加預計將影響市場的增長。

脊柱植入物和手術器械市場的主要驅動力是脊柱疾病負擔的增加、微創手術需求的增加以及骨移植產品的技術進步。 脊髓疾病 (SD) 和相關疼痛是一個主要的醫學、社會和經濟問題,因為它們在普通人群中的患病率很高,而且患者人數不斷增加。 根據英國脊髓損傷協會 2021,每年約有 2500 人受傷或被診斷出脊髓損傷,估計英國有 50,000 人患有脊髓損傷。 對於 SD,患者會經歷假關節疼痛,其中大部分是由於脊柱的退行性變化,涉及椎間盤、小關節和軟組織。

脊柱相關疾病是臨床醫學中最常遇到的問題之一。 收購也是市場增長的驅動力之一。 例如,2020 年 11 月,美敦力收購了 Medicrea International,該公司專門從事具有人工智能、預測建模和患者特異性植入物的脊柱外科手術。 同樣,2021 年 2 月,NuVasive, Inc. 收購了 Simplify Medical,這是一家私人控股的 Simplify Cervical Artificial Disc(Simplify Disc)開發商,用於全頸椎置換術(cTDR)。 因此,這樣的市場發展將促進未來的市場增長。

頸椎病、椎間盤脫落、椎管狹窄、椎間盤突出和椎體骨折等脊柱疾病發病率的增加正在推動全球脊柱植入物和手術器械市場的發展。 因此,脊柱治療和設備中新穎有效技術的開發有望推動對這些植入物和設備的需求。 然而,高昂的治療成本和嚴格的監管審批程序可能會阻礙市場增長。

脊柱植入物和手術器械的市場趨勢

預計在預測期內微創手術將保持顯著的市場增長

研究的增加、技術創新以及主要參與者之間的合作夥伴關係等因素預計會增加市場份額。 灌注技術的創新、脊柱融合的改進以及專業手術器械和機器人技術的發展提供了將脊柱手術推進到微創方法所需的工具。 微創脊柱手術 (MIS) 的目標是穩定椎骨和脊柱關節並減輕脊神經的壓力,通常是由於脊柱不穩定、骨贅、椎間盤突出、脊柱側凸和脊柱腫瘤等疾病造成的。它是關於減輕。

微創脊柱手術的許多發展有望促進市場的增長。 例如,2020 年 7 月,joimax 與澳大利亞醫療器械經銷商 LifeHealthcare 建立了新的合作夥伴關係,通過微創內窺鏡脊柱手術為考慮進行脊柱手術的患者提供廣泛的手術選擇。 同樣,2021 年 10 月,專注於治療脊柱疾病的手術解決方案的全球醫療技術公司 SeaSpine Holdings Corporation 在美國和澳大利亞完成了 7D 經皮脊柱模塊的首例稻田。 7D Flash Navigation System 使 SeaSpine 能夠應對全球估計約 40 億美元的微創脊柱手術市場。 7D 經皮模塊的加入使微創脊柱手術程序能夠以高精度和高效率進行有效導航。 這種技術進步正在影響研究目標市場的全球增長。

因此,由於上述因素,預計在預測期內市場將出現顯著的市場增長。

在預測期內,北美將佔據所研究市場的很大份額

北美脊柱植入物和手術器械市場佔有很大份額,預計在預測期內將呈現類似趨勢。 該地區的增長受到技術進步、期望更高水平功能的老年患者以及鼓勵複雜融合手術的報銷模式的推動,這有助於推動脊柱植入物和手術器械市場。

產品批准也是市場增長的一個因素。 例如,2020 年 12 月,ActaStim-S 脊柱融合刺激器獲得 FDA(食品和藥物管理局)的批准。 這是一種小型、可穿戴、非手術骨生長刺激器 (BGS),包括可充電電池組和充電裝置,以及帶導線的電極。 BGS 向佩戴在臀□□部的電極輸送電流,以促進骨骼生長並支持脊柱融合。

同樣,2020 年 3 月,Orthofix Medical Inc. 完成了與用於股骨和脛骨肢體延長的 FITBONE 髓內延長系統相關的資產收購。 此次收購還包括其他正在開發的潛在技術,包括 FITSPINE,這是一種用於治療早發性脊柱側凸的非癒合手術系統。

同樣,2020 年 12 月,Zimmer Biomet 收購了新澤西州的 A&E Medical Corporation 及其整個胸骨閉合裝置產品組合。 該地區主要市場參與者的此類發展預計將促進未來的市場增長。

因此,由於上述因素,預計在預測期內北美地區的市場將顯著增長。

脊柱植入物和手術器械市場競爭分析

這個市場競爭相當激烈,有幾家大大小小的參與者。 市場參與者關注技術進步和產品成本降低。 市場上的主要參與者包括 Alphatec Spine Inc.、Depuy Synthes(強生)、Globus Medical Inc.、NuVasive Inc、Orthofix Holdings Inc、RTI Surgical Inc、Stryker Corporation、Zimmer Biomet。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 脊柱疾病負擔加重
    • 對微創手術的需求不斷增長
    • 植骨材料技術進展
  • 市場製約因素
    • 手術費用高
    • 嚴格的監管審批程序
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模:100 萬美元)

  • 按技術
    • 脊柱固定和融合技術
    • 椎體壓縮性骨折治療技術
    • 運動維護/非工會技術
    • 其他技術
  • 按產品分類
    • 用於胸椎和腰椎融合的設備
    • 頸椎固定裝置
    • 椎體壓縮性骨折治療儀
    • 脊柱生物製劑
    • 非融合裝置
    • 脊柱骨骼刺激器
    • 其他產品
  • 按手術類型
    • 開放手術
    • 微創手術
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Alphatec Spine Inc.
    • Depuy Synthes(Johnson & Johnson)
    • Globus Medical Inc.
    • Spineart
    • Medtronic Plc
    • NuVasive Inc.
    • Orthofix Holdings Inc.
    • RTI Surgical Inc
    • Stryker Corporation
    • Zimmer Biomet
    • Advin Healthcare
    • DeGen Medical Inc.
    • Osseus

第7章 市場機會與今後動向

簡介目錄
Product Code: 64428

The spinal implants and surgical devices market is projected to register a CAGR of 5.6% during the forecast period (2022-2027).

The COVID-19 pandemic had an effect on the country's healthcare systems with significant impacts not only on the patients infected with COVID-19 but on others as well, which resulted in the cancellation of spinal surgeries to manage and reserve the resources and many hospitals are facing a shortage of professionals to assist these surgeries. For instance, the British Journal of Surgery article titled 'Elective surgery cancellations due to the COVID-19 pandemic: global predictive modeling to inform surgical recovery plans' published in May 2020 reported that around 48,728 surgical procedures per week were canceled in India which estimates around 585,000 surgical procedures for 12 weeks. Thus, given the above-mentioned factors, there could be a significant impact on the studied market during the COVID-19 pandemic. The increasing cases of COVID-19 globally, it is likely to show an impact on the market growth.

The spinal implants and surgical devices market is primarily driven by the increasing burden of spinal disorders, rising demand for minimally-invasive surgeries, and technological advancements in bone grafting products. Spine disorders (SD) and the associated pain are a major medical, social, and economic problem, due to their high prevalence and the ever-increasing number of patients in the general population. According to Spinal Injury Association United Kingdom 2021, about 2500 people are injured or diagnosed with spinal cord injuries every year and an estimated 50,000 people are living with spinal cord injuries in the United Kingdom. In most SD cases, patients experience pseudo-radicular pain, and in the majority, the pain results from degenerative changes in the spine, involving the intervertebral discs, facet joints, and soft tissues.

Spine-related disorders are among the most frequently encountered problems in clinical medicine. The acquisition is another factor in the growth of the market. For instance, in November 2020, Medtronic acquired Medicrea International which specializes in spinal surgery through artificial intelligence, predictive modeling, and patient-specific implants. Similarly, in February 2021, NuVasive, Inc. acquired Simplify Medical, a privately held company and developer of the Simplify Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR). Hence, such developments would increase market growth in the future.

The increasing incidence of spinal disorders, such as cervical spondylitis, prolapsed intervertebral disc, spinal stenosis, herniated disc, and vertebral fracture, helped in driving the spinal implants and surgical devices market, globally. Hence, the development of novel and effective technologies in spine care and devices is anticipated to drive the demand for these implants and devices. However, the high cost of the procedures and stringent regulatory approval procedures are likely to hinder the market growth.

Spinal Implants & Surgical Devices Market Trends

Minimally Invasive Surgery is Expected to Hold the Significant Market Growth Over the Forecast Period

Factors such as increasing research studies, and technological innovations coupled with partnerships between key market players are likely to increase the market share. With innovations in perfusion techniques, refinement of spinal fusion, and the development of specialized surgical instruments and robotic technology, spinal surgery was provided with the necessary tools to progress to less invasive approaches. The goal of the minimally invasive spine (MIS) surgery is to stabilize the vertebral bones and spinal joints and/or relieve the pressure being applied to the spinal nerves often a result of conditions such as spinal instability, bone spurs, herniated discs, scoliosis or spinal tumors.

Many developments are taking place concerning minimally invasive spine surgery which will boost the market growth. For instance, in July 2020, joimax entered into a new partnership with Australian medical device distributor, LifeHealthcare to provide a broader surgical choice for patients considering spinal surgery with minimally invasive endoscopic spine surgery. Similarly, in October 2021, SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, completed the first cases in both the United States and Australia for the 7D Percutaneous Spine Module. 7D Flash Navigation System allows SeaSpine to address the minimally invasive spine surgery market, which SeaSpine estimates at approximately USD 4 billion worldwide. The addition of the 7D Percutaneous Module allows effectively navigating minimally invasive spine surgery procedures with a high level of accuracy and efficiency. Such technological advancements are impacting the growth of the studied market globally.

Thus, owing to the abovementioned factors the market is expected to have significant market growth over the forecast period.

North America accounted for the Large Share in the Studied Market Over the Forecast Period

North American spinal implants and surgical devices market holds a significant share and is expected to show a similar trend over the forecast period. The growth in the region is driven by technological advancement, elderly patients expecting a higher level of function, and reimbursement models that incentivize complex fusion surgery and have helped in driving the spinal implants and surgical devices market.

Product approval is another factor in the growth of the market. For instance, in December 2020, ActaStim-S Spine Fusion Stimulator was approved by the Food and Drug Administration (FDA). It is a small, wearable, nonsurgical bone growth stimulator (BGS) device, that includes a rechargeable battery pack and charging unit, and electrodes with lead wires. The BGS sends an electrical current to the electrodes attached to the lower back to promote bone growth and support spinal fusion.

Similarly, in March 2020, Orthofix Medical Inc. completed the acquisition of assets associated with the FITBONE intramedullary lengthening system for limb lengthening of the femur and tibia bones. The transaction also includes other potential applications of the technology which are in development, including the FITSPINE system for fusion-less surgery to treat early-onset scoliosis.

Similarly, in December 2020, Zimmer Biomet acquired New Jersey-based A&E Medical Corporation and its complete portfolio of sternal closure devices. Such developments by the key market players in the region are likely to increase the market growth in the upcoming period.

Thus, owing to the abovementioned factors the market is expected to have significant growth in the North American region over the forecast period.

Spinal Implants & Surgical Devices Market Competitor Analysis

The market studied is moderately competitive, owing to the presence of a few major and small players in the market. The market players are focusing on technological advancements and reducing the cost of the products. Some of the major players in the market are Alphatec Spine Inc., Depuy Synthes (Johnson & Johnson), Globus Medical Inc., NuVasive Inc., Orthofix Holdings Inc., RTI Surgical Inc., Stryker Corporation, and Zimmer Biomet.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Spinal Disorders
    • 4.2.2 Rising Demand for Minimally-invasive Surgeries
    • 4.2.3 Technological Advancements in Bone Grafting Products
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Procedures
    • 4.3.2 Stringent Regulatory Approval Procedure
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Technology
    • 5.1.1 Spinal Fusion and Fixation Technologies
    • 5.1.2 Vertebral Compression Fracture Treatment
    • 5.1.3 Motion Preservation/Non-fusion Technologies
    • 5.1.4 Other Technologies
  • 5.2 By Product
    • 5.2.1 Thoracic Fusion and Lumbar Fusion Devices
    • 5.2.2 Cervical Fusion Devices
    • 5.2.3 Vertebral Compression Fracture Treatment Devices
    • 5.2.4 Spinal Biologics
    • 5.2.5 Non-fusion Devices
    • 5.2.6 Spine Bone Stimulators
    • 5.2.7 Other Products
  • 5.3 By Type of Surgery
    • 5.3.1 Open Surgery
    • 5.3.2 Minimally-invasive Surgery
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alphatec Spine Inc.
    • 6.1.2 Depuy Synthes (Johnson & Johnson)
    • 6.1.3 Globus Medical Inc.
    • 6.1.4 Spineart
    • 6.1.5 Medtronic Plc
    • 6.1.6 NuVasive Inc.
    • 6.1.7 Orthofix Holdings Inc.
    • 6.1.8 RTI Surgical Inc
    • 6.1.9 Stryker Corporation
    • 6.1.10 Zimmer Biomet
    • 6.1.11 Advin Healthcare
    • 6.1.12 DeGen Medical Inc.
    • 6.1.13 Osseus

7 MARKET OPPORTUNITIES AND FUTURE TRENDS